We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Team Identifies Checkpoint Target for Colorectal Cancer Immunotherapy

News   May 12, 2020 | Original story from Indiana University

 
Team Identifies Checkpoint Target for Colorectal Cancer Immunotherapy
 
 
Advertisement
 

RELATED ARTICLES

Gut Microbiota Composition Indicates Efficacy of Drugs in Inflammatory Bowel Diseases

News

Researchers investigated whether any predictors associated with infliximab therapy could be identified in the gut microbiota.

READ MORE

Antiviral Enzymes Convert Pre-Leukemia Stem Cells Into Leukemia

News

In response to inflammation, two enzymes called APOBEC3C and ADAR1 work together to trigger the transformation of pre-cancer stem cells to cancer stem cells in leukemia.

READ MORE

Circulating Myeloid Immune Cells Linked to Severe COVID-19

News

Patients with severe COVID-19 have significantly elevated levels of a certain type of immune cells in their blood, called myeloid-derived suppressor cells. The study may bring an increased understanding of how early immune responses impact disease severity.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE